Ovarian cancer and hormone replacement therapy in the Million Women study
Background: Ovarian cancer is the fourth most common cancer in women in the UK, with about 6700 developing the malignancy and 4600 dying from it every year. However, there is limited information about the risk of ovarian cancer associated with the use of
|Collections||ANU Research Publications|
|Source:||Lancet, The (UK edition)|
|01_Beral_Ovarian_cancer_and_hormone_2007.pdf||6.44 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.